Let's meet for coffee
Schedule a meeting or connect with me on LinkedIn to discuss your upcoming study and how PSI can help.
Senior Director, Operations
Mobile: (574) 309-1426
Global CRO focused on pivotal Phase 2 and 3 trials
As a leading oncology CRO, we have diverse experience in various classes of small molecules and biologics across a broad spectrum of cancers, including lung, breast, GI, GU, skin, leukemias, lymphomas, multiple myeloma, and MPNs. We work collaboratively with our Valued Sites to develop streamlined processes which decrease start-up timelines and promote efficiencies for our sponsors, sites, and PSI.
Read our latest white paper
Learn more with the resources below
Find out how PSI helped one of our partners cut their startup timelines in half on a global HemOnc study.